Just because you can (and radiotherapy seems to be effective), doesn’t mean you should

Oliver Pech; Saleh A. Alqahtani

doi:10.1055/a-1246-3062

Endoscopy, Inhaltsverzeichnis

Endoscopy 2020; 52(12): 1075-1076
DOI: 10.1055/a-1246-3062

Editorial

Just because you can (and radiotherapy seems to be effective), doesn’t mean you should

Referring to Zhang Y et al. p. 1066–1074

Oliver Pech

¹Department of Gastroenterology and Interventional Endoscopy, St. John of God Hospital, Teaching Hospital of the University of Regensburg, Regensburg, Germany

,

Saleh A. Alqahtani

²Department of Gastroenterology and Hepatology, Johns Hopkins Hospital, Baltimore, Maryland, USA

References
1 Pech O, May A, Gossner L. et al. Curative endoscopic resection in patients with early esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007; 39: 30-35
2 Takahashi H, Arimura Y, Masao H. et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-264
3 Zhang Y, Liu L, Wang Q. et al. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a early esophageal squamous cell carcinoma: a prospective randomized controlled trial. Endoscopy 2020; 52: 1066-1074
4 Minashi K, Nihei K, Mizusawa J. et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology 2019; 157: 382-390
5 Muto M, Hironaka S, Nakane M. et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002; 56: 517-521
6 Katada C, Yokoyama T, Yano T. et al. Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions. Dis Esophagus 2020;
7 Jaiswal S, Jaiswal S, Kumar R. et al. Field cancerization: concept and clinical implications in head and neck squamous cell carcinoma. J Exp Ther Oncol 2013; 10: 209-214